Abstract
Objective
There is a lack of strong evidence for use of expensive bone substitutes. This study compares perioperative data and patient reported quality-of-life outcomes across the varied types of bone graft extenders. The study analyzes the existing Quality and Outcomes Database and evaluates patient reported outcomes for 1–3 level lumbar fusion procedures comparing across different types of biologics bone graft.
Methods
We retrospectively analyzed a prospectively collected data registry. Bone graft implant data were collected and grouped into the following categories: (1) Autograft with basic allograft (2) Enhanced, synthetic, or cellular allograft (3) Use of BMP. Preoperative and 1 year patient reported outcomes and perioperative data from the prospective collected registry were analyzed.
Results
There were 384 patients included in this study. There were 168 (43.8%) patients in group 1, 133 (34.6%) patients in group 2, and 83 (21.6%) in group 3. There were no group differences in baseline or 1 year back pain, leg pain, ODI, or EQ-5D. The GLM Repeated Measures results indicate a significant difference within each of the three groups between the preoperative and postoperative measures for back pain, leg pain, ODI, and EQ-5D. The change over time was not significantly different between the groups.
Conclusions
Bone graft extenders are a significant contributor to the cost of lumbar fusion. This study demonstrates no difference in preoperative, and 1 year patient reported outcomes between the three groups. There was no significant difference in rate of reoperations across the three groups.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Freburger JK, Holmes GM, Agans RP et al (2009) The rising prevalence of chronic low back pain. Arch Intern Med 169(3):251–258. https://doi.org/10.1001/archinternmed.2008.543
Katz JN (2006) Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am 88(Suppl 2):21–24. https://doi.org/10.2106/jbjs.E.01273
Deyo RA, Gray DT, Kreuter W, Mirza S, Martin BI (2005) United States trends in lumbar fusion surgery for degenerative conditions. Spine (Phila Pa 1976) 30(12):1441–1445. https://doi.org/10.1097/01.brs.0000166503.37969.8a
Beckerman D, Esparza M, Lee SI et al (2020) Cost analysis of single-level lumbar fusions. Glob Spine J 10(1):39–46. https://doi.org/10.1177/2192568219853251
Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA (1996) Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329:300–309. https://doi.org/10.1097/00003086-199608000-00037
Bone Grafts And Substitutes Market Worth $4.94 Billion By 2030
Grand View Research (2022) January 2022. 2023. https://www.grandviewresearch.com/press-release/global-bone-grafts-substitutes-market
Yoon ST, Boden SD (2004) Spine fusion by gene therapy. Gene Ther 11(4):360–367. https://doi.org/10.1038/sj.gt.3302203
Gupta A, Kukkar N, Sharif K, Main BJ, Albers CE, El-Amin Iii SF (2015) Bone graft substitutes for spine fusion: a brief review. World J Orthop 6(6):449–456. https://doi.org/10.5312/wjo.v6.i6.449
Louis-Ugbo J, Murakami H, Kim HS, Minamide A, Boden SD (2004) Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion. Spine (Phila Pa 1976) 29(4):360–366. https://doi.org/10.1097/01.brs.0000090823.12652.f9
Choi Y, Oldenburg FP, Sage L, Johnstone B, Yoo JU (2007) A bridging demineralized bone implant facilitates posterolateral lumbar fusion in New Zealand white rabbits. Spine (Phila Pa 1976) 32(1):36–41. https://doi.org/10.1097/01.brs.0000250982.41666.55
Roberts TT, Rosenbaum AJ (2012) Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing. Organogenesis 8(4):114–124. https://doi.org/10.4161/org.23306
Wozney JM (2002) Overview of bone morphogenetic proteins. Spine (Phila Pa 1976) 27(16 Suppl 1):S2–S8. https://doi.org/10.1097/00007632-200208151-00002
Mehler MF, Mabie PC, Zhang D, Kessler JA (1997) Bone morphogenetic proteins in the nervous system. Trends Neurosci 20(7):309–317. https://doi.org/10.1016/s0166-2236(96)01046-6
Urist MR, Silverman BF, Büring K, Dubuc FL, Rosenberg JM (1967) The bone induction principle. Clin Orthop Relat Res 53:243–283
Urist MR, Strates BS (1970) Bone formation in implants of partially and wholly demineralized bone matrix. Including observations on acetone-fixed intra and extracellular proteins. Clin Orthop Relat Res 71:271–8
Polly DW Jr, Ackerman SJ, Shaffrey CI et al (2003) A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics 26(10):1027–1037. https://doi.org/10.3928/0147-7447-20031001-12
Dimar JR, Glassman SD, Burkus KJ, Carreon LY (2006) Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976) 31(22):2534–2539. https://doi.org/10.1097/01.brs.0000240715.78657.81
Boden SD, Zdeblick TA, Sandhu HS, Heim SE (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976) 25(3):376–381. https://doi.org/10.1097/00007632-200002010-00020
Faundez A, Tournier C, Garcia M, Aunoble S, Le Huec JC (2016) Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review. Int Orthop 40(6):1309–1319. https://doi.org/10.1007/s00264-016-3149-8
Alt V, Chhabra A, Franke J, Cuche M, Schnettler R, Le Huec JC (2009) An economic analysis of using rhBMP-2 for lumbar fusion in Germany, France and UK from a societal perspective. Eur Spine J 18(6):800–806. https://doi.org/10.1007/s00586-009-0935-7
Glassman SD, Dimar JR 3rd, Burkus K et al (2007) The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers. Spine (Phila Pa 1976) 32(15):1693–1698. https://doi.org/10.1097/BRS.0b013e318074c366
Blackburn CW, Thompson NR, Tanenbaum JE, Passerallo AJ, Mroz TE, Steinmetz MP (2019) Association of cost savings and surgical quality with single-vendor procurement for spinal implants. JAMA Netw Open 2(11):e1915567. https://doi.org/10.1001/jamanetworkopen.2019.15567
Galimberti F, Lubelski D, Healy AT et al (2015) A systematic review of lumbar fusion rates with and without the use of rhBMP-2. Spine (Phila Pa 1976) 40(14):1132–1139. https://doi.org/10.1097/brs.0000000000000971
Funding
We have no disclosures.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Cumulative proportion of reoperations in each group over time. c2 = 0.15, p=0.928
Supplementary file1 (PNG 243 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zeitouni, D., Pfortmiller, D., Coric, D. et al. Does type of bone graft matter? A retrospective review of the use of biological bone grafts in patients undergoing elective 1–3 level spinal interbody fusion. Eur Spine J 33, 1340–1346 (2024). https://doi.org/10.1007/s00586-023-08108-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-023-08108-2